Abstract
Hepcidin is a small protein involved in iron metabolism that also exhibits antibacterial and antifungal activities. Since its discovery in 2000, hepcidin has been extensively studied in many research centers. Usage of natural and synthetic hepcidin inhibitors can be applied as a powerful therapeutic tool that targets multiple types of anemia. In addition, the protein itself has a potential to placate increased absorption of iron in patients with β-thalassemia. Previous studies have characterized mechanisms of hepcidin synthesis as well as its biological activity, however methods enabling estimation of its concentration in biological materials remain obscure. The physiological role of hepcidin in iron metabolism as well as methods of its determination in serum and urine samples are described in this paper. Furthermore, the possible role of hepcidin and its molecular antagonists in health improvement is considered.
Keywords: Iron, Hepcidin, Hepcidin assays, ELISA, SELDI-TOF-MS, Biological activity, Antibacterial, Antifungal, Hepcidin inhibitors, thalassemia
Current Pharmaceutical Analysis
Title: Hepcidin: Biological Activity, Analytical Methods in Biological Fluids, Clinical Applications and Antagonists. A Short Review
Volume: 7 Issue: 3
Author(s): Artur Slomka, Marcin Koba, Arleta Kulwas and Ewa Zekanowska
Affiliation:
Keywords: Iron, Hepcidin, Hepcidin assays, ELISA, SELDI-TOF-MS, Biological activity, Antibacterial, Antifungal, Hepcidin inhibitors, thalassemia
Abstract: Hepcidin is a small protein involved in iron metabolism that also exhibits antibacterial and antifungal activities. Since its discovery in 2000, hepcidin has been extensively studied in many research centers. Usage of natural and synthetic hepcidin inhibitors can be applied as a powerful therapeutic tool that targets multiple types of anemia. In addition, the protein itself has a potential to placate increased absorption of iron in patients with β-thalassemia. Previous studies have characterized mechanisms of hepcidin synthesis as well as its biological activity, however methods enabling estimation of its concentration in biological materials remain obscure. The physiological role of hepcidin in iron metabolism as well as methods of its determination in serum and urine samples are described in this paper. Furthermore, the possible role of hepcidin and its molecular antagonists in health improvement is considered.
Export Options
About this article
Cite this article as:
Slomka Artur, Koba Marcin, Kulwas Arleta and Zekanowska Ewa, Hepcidin: Biological Activity, Analytical Methods in Biological Fluids, Clinical Applications and Antagonists. A Short Review, Current Pharmaceutical Analysis 2011; 7 (3) . https://dx.doi.org/10.2174/157341211796353309
DOI https://dx.doi.org/10.2174/157341211796353309 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Interplay of Carotenoids with Cigarette Smoking: Implications in Lung Cancer
Current Medicinal Chemistry Chronic Coronary Syndrome: Overcoming Clinical Practice Guidelines. The role of the COMPASS Strategy
Current Cardiology Reviews Mitochondrial Therapeutics for Cardioprotection
Current Pharmaceutical Design Utilization of Evidence-Based Secondary Prevention Medications at the Time of Discharge in Patients with Acute Coronary Syndrome (ACS) in Qatar
Current Vascular Pharmacology Evaluation of Current Pharmacological Treatment Options in the Management of Rett Syndrome: From the Present to Future Therapeutic Alternatives.
Current Clinical Pharmacology Electrocardiographic and Cardiac Autonomic Indices - Implications of Sex-Specific Risk Stratification in Women After Acute Myocardial Infarction
Current Pharmaceutical Design Recent Advancements in Diagnosis and Therapy of Liver Cirrhosis
Current Drug Targets Inhibition of Receptor Tyrosine Kinases in Combination with Chemotherapy for the Treatment of Breast Cancer
Anti-Cancer Agents in Medicinal Chemistry ACE2; an ACE up the Sleeve?
Current Enzyme Inhibition The Potential Application of Biomaterials in Cardiac Stem Cell Therapy
Current Medicinal Chemistry COX-2, Cell Proliferation and PMA in Head-and-Neck Cancer Cells
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Mechanisms of Anorexia Cancer Cachexia Syndrome and Potential Benefits of Traditional Medicine and Natural Herbs
Current Pharmaceutical Biotechnology Sphingolipids in Inflammation: Roles and Implications
Current Molecular Medicine The Role of Mineralocorticoid Receptor Antagonists in the Management of Heart Failure with Preserved Ejection Fraction
Current Pharmaceutical Design Current Pharmacological Treatment of Pulmonary Arterial Hypertension
Current Clinical Pharmacology Conventional (Continuous) EEG Monitoring in the NICU
Current Pediatric Reviews MCP-1/CCL2 as a Therapeutic Target in Myocardial Infarction and Ischemic Cardiomyopathy
Inflammation & Allergy - Drug Targets (Discontinued) Prevention and Treatment of Regimen-Related Mucosal Toxicity
Recent Patents on Anti-Cancer Drug Discovery Diselenides and Selenocyanates as Versatile Precursors for the Synthesis of Pharmaceutically Relevant Compounds
Current Organic Synthesis Natural and Synthetic Agents Targeting Inflammation and Angiogenesis for Chemoprevention of Prostate Cancer
Current Cancer Drug Targets